CASSANDRA HEMBY: Open Payments
NPI 1235910647 · WINTER HAVEN, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,047 in 165 payments from 26 companies in 2025. Trend: 2023 $72 · 2024 $2,044 · 2025 $3,047
Food & beverage: $2,888Education: $159
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $562 |
| UCB, Inc. | 26 | $375 |
| Janssen Biotech, Inc. | 21 | $307 |
| E.R. Squibb & Sons, L.L.C. | 13 | $244 |
| AstraZeneca Pharmaceuticals LP | 8 | $228 |
| Amgen Inc. | 14 | $198 |
| GlaxoSmithKline, LLC. | 9 | $141 |
| Mallinckrodt Hospital Products Inc. | 9 | $138 |
| SANOFI-AVENTIS U.S. LLC | 1 | $99 |
| PFIZER INC. | 5 | $88 |
Products named: RINVOQ, Bimzelx, TREMFYA, ORENCIA, SAPHNELO, KEVZARA, BENLYSTA, OTEZLA.
Industry payments across FL — which companies pay providers there.
